Controls & Reference Materials

Seraseq® ctDNA EGFR Panel Reference Material AF1%

Material Number 0710-0718
Size 1 x 5 mL
Inventory Status In Stock
Unit EA

Driver mutations in the EGFR, BRAF, and KRAS genes represent a combined ~60% of all genomic variants driving oncogenesis of many solid tumor diseases, especially lung cancer. SeraCare is expanding its Seraseq liquid biopsy portfolio with the addition of low-plex (single-gene) reference materials for clinically-validated biomarkers as ground-truth standards for molecular testing of circulating tumor DNA patient samples by PCR or NGS technologies. These products are designed for validation and standardization of clinical biomarkers in CLIA/CAP-accredited laboratory developed tests (LDTs).

The Seraseq ctDNA EGFR Panel Reference Material AF1% product has an allele frequency of 1%.

  • Size distribution similar to native cfDNA
  • Offered in a full-process plasma-like material capable of assessing the entire workflow from extraction through analysis
  • Mutation precisely quantitated with digital PCR
  • Single well-characterized GM24385 human genomic DNA as background wild-type material
  • Manufactured in GMP-compliant and ISO 13485-certified facilities

    Seraseq ctDNA EGFR Panel Reference Material AF1%

    Doc type
    Product Report
    Lot #

    Seraseq ctDNA EGFR Panel Reference Material AF1% and AF0.1%

    Doc type
    Package Insert